Stay updated on Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.

Latest updates to the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page
- Check3 days agoChange DetectedNo additions or deletions were detected. The page content and structure appear unchanged.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check32 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference2%

- Check39 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Lung cancer, expanding the page to cover genetic aspects of lung cancer. No deletions were reported.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' element has been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.1%

Stay in the know with updates to Genetic Predictors of Benefit to Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.